eHealth (EHTH) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
16 Jan, 2026Executive summary
Q3 2024 saw strong Medicare enrollment growth, with Medicare submissions up 22% and Medicare Advantage submissions up 26% year-over-year, driven by enhanced agent force, marketing, and digital experience.
Total approved members were flat for the quarter and down 2% for the nine months, as declines in other segments offset Medicare gains.
Early AEP performance exceeded expectations, with increased call volume, online visits, and conversion rates, supported by robust outreach and plan changes.
Completed AEP preparations, including achieving licensed agent headcount targets, robust training, and platform enhancements.
Extended term loan maturity to February 2026 with improved interest rate terms, enhancing financial flexibility.
Financial highlights
Q3 2024 total revenue was $58.4M, down 10% year-over-year, mainly due to lower positive net adjustment (tail) revenue; non-GAAP total revenue excluding tail revenue increased 9% year-over-year.
Q3 2024 GAAP net loss was $42.5M, a 15% increase year-over-year; non-GAAP net loss improved 6% year-over-year.
Adjusted EBITDA was $(34.8)M, compared to $(28.1)M in Q3 2023; adjusted EBITDA excluding net adjustment revenue improved by $4.3M year-over-year.
Operating cash flow for the trailing twelve months ended 9/30/2024 was $(24.1)M; cash, cash equivalents, and marketable securities totaled $117.8M as of September 30, 2024.
Recognized $7.4M in non-cash asset impairment charges and $2.0M in restructuring charges in the nine months ended September 30, 2024.
Outlook and guidance
Full-year 2024 revenue expected between $470M and $495M, with GAAP net loss projected between $(36.5)M and $(22.0)M, and adjusted EBITDA expected between $7.5M and $25.0M.
Guidance includes estimated positive net adjustment revenue of $14–$20M and operating cash flow guidance of $(10.0)M to $0.0M.
Operational priorities include growing revenue, achieving positive adjusted EBITDA, advancing omni-channel enrollment, and expanding the product portfolio.
Confident in sufficient liquidity to execute strategy through 2025 and 2026.
Anticipates significant consumer demand in the upcoming AEP, driven by plan changes and competitor exits.
Latest events from eHealth
- 2025 saw robust profit and margin growth; 2026 will emphasize cash flow and efficiency.EHTH
Q4 202525 Feb 2026 - Medicare growth and cost controls drove raised 2024 outlook despite wider GAAP net loss.EHTH
Q2 20242 Feb 2026 - Transformation, tech, and diversification drive profitable growth and sector leadership.EHTH
Sidoti Micro-Cap Virtual Conference2 Feb 2026 - Plans to offer up to $300M in securities to fund operations and potential strategic investments.EHTH
Registration Filing16 Dec 2025 - Record Q4 2024 revenue and net income, led by Medicare Advantage growth and margin gains.EHTH
Q4 20243 Dec 2025 - Shareholders will vote on director elections, auditor ratification, executive pay, and equity plan changes.EHTH
Proxy Filing1 Dec 2025 - Shareholders will vote to double the ESPP share limit to 1,000,000 at the June 2024 meeting.EHTH
Proxy Filing1 Dec 2025 - Amendment to equity plan aims to fuel growth, align incentives, and attract top talent.EHTH
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, auditor, executive pay, and equity plan increase.EHTH
Proxy Filing1 Dec 2025